Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

Journal article

Peer reviewed

Aman U Buzdar, Jean-Paul Guastalla, Jean-Marc Nabholtz, Jack Cuzick and ATAC Trialists Grp

Cancer, Vol.107(3), pp.472-480

01/08/2006

PMID: 16804925

Abstract

Biological and medical sciences

Gynecology. Andrology. Obstetrics

Mammary gland diseases

Medical sciences

Tumors

1 Record Views

Title: Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial
Creators - without role: Aman U Buzdar - The University of Texas MD Anderson Cancer Center
Jean-Paul Guastalla - Centre Léon Bérard
Jean-Marc Nabholtz - Korean Breast Cancer Society
Jack Cuzick - Cancer Research UK
ATAC Trialists Grp
Publication Details: Cancer, Vol.107(3), pp.472-480
Publisher: Wiley-Liss
Identifiers: 9946130208331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article